Halley E Gilbert has sold stock and made no open-market buys since May 2016
Director at Arcutis Biotherapeutics, Inc., and 2 other companies
SEC CIK 0001601360 · Filings on SEC.gov ↗
Companies
Every filing
14 filings since May 2016, newest first
Arcutis Biotherapeutics, Inc.
Director
Vaxcyte, Inc.
Director
Ironwood Pharmaceuticals Inc
Chief Admin Officer and SVP
Ironwood Pharmaceuticals Inc
Chief Admin Officer and SVP
Ironwood Pharmaceuticals Inc
Chief Admin Officer and SVP
Ironwood Pharmaceuticals Inc
Chief Admin Officer and SVP
Ironwood Pharmaceuticals Inc
General Counsel
Ironwood Pharmaceuticals Inc
General Counsel
Ironwood Pharmaceuticals Inc
General Counsel
Ironwood Pharmaceuticals Inc
General Counsel
Ironwood Pharmaceuticals Inc
General Counsel
Ironwood Pharmaceuticals Inc
General Counsel
Ironwood Pharmaceuticals Inc
General Counsel
Ironwood Pharmaceuticals Inc
General Counsel
About Halley E Gilbert
Halley E. Gilbert is a corporate director and biopharmaceutical executive who serves as a Director at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), having joined the company’s board in May 2020.( In her role at Arcutis, she contributes more than two decades of experience in legal affairs, corporate and business development, compliance, and government affairs, and serves on key board committees including the audit and nominating and governance functions.( Gilbert has recently engaged in insider transactions as a director of Arcutis, including the sale of common stock reported in November 2025, underscoring her status as a corporate insider.(
Gilbert is currently Chief Legal Officer and Chief Operating Officer of Tubulis GmbH, a private biotechnology company focused on antibody-drug conjugates, where she oversees legal and administrative functions and helps shape corporate strategy and U.S. expansion.( Previously, she held senior leadership roles at Ironwood Pharmaceuticals as Senior Vice President for Corporate Development and Chief Administrative Officer, and earlier as Senior Vice President, Chief Legal Officer, and Corporate Secretary, after joining Ironwood as the founding member of its legal department.( Her earlier career includes serving as Vice President, Deputy General Counsel at Cubist Pharmaceuticals, corporate counsel at Genzyme Corp., and beginning her legal career at Skadden, Arps, Slate, Meagher & Flom LLP specializing in mergers and acquisitions and securities law.( Gilbert has also built a significant board portfolio, having served or serving on the boards of CytomX Therapeutics, Vaxcyte, Arcutis, Dermira (prior to its acquisition by Eli Lilly), and Achaogen, reflecting broad governance experience across commercial-stage and clinical-stage biopharmaceutical companies.( She holds a B.A. in Political Science from Tufts University and a J.D. from Northwestern University School of Law (Northwestern University Pritzker School of Law).(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.